Penumbra - Public Comps and Valuation Multiples

Penumbra Overview

About Penumbra

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

Founded

2004

HQ

Employees

4.5K+

Website

penumbrainc.com

Sectors

Medical Devices
DeepTech
HealthTech

Financials

LTM Revenue $1.3B

LTM EBITDA $237M

EV

$10.0B

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Penumbra Financials

As of September 2025, Penumbra reported last 12-month revenue of $1.3B and EBITDA of $237M.

In the same period, Penumbra generated $888M in LTM gross profit and $140M in net income.

See Penumbra valuation multiples based on analyst estimates

Penumbra P&L

In the most recent fiscal year, Penumbra reported revenue of $1.2B and EBITDA of $46.0M.

Penumbra expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Penumbra valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$1.3B	XXX	$1.2B	XXX	XXX	XXX
Gross Profit	$888M	XXX	$755M	XXX	XXX	XXX
Gross Margin	67%	XXX	63%	XXX	XXX	XXX
EBITDA	$237M	XXX	$46.0M	XXX	XXX	XXX
EBITDA Margin	18%	XXX	4%	XXX	XXX	XXX
EBIT	$167M	XXX	$86.2M	XXX	XXX	XXX
EBIT Margin	13%	XXX	7%	XXX	XXX	XXX
Net Profit	$140M	XXX	$14.0M	XXX	XXX	XXX
Net Margin	10%	XXX	1%	XXX	XXX	XXX
Net Debt	XXX	XXX	n/a	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Penumbra including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $1.3B. EBITDA for the last twelve months was $237M. In the most recent fiscal year, Penumbra achieved $1.2B in revenue and $46.0M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$1.3B	Analyst estimates available to subscribers	$1.2B	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$888M	Analyst estimates available to subscribers	$755M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	66.7% gross margin	Analyst estimates available to subscribers	63.2% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$237M	Analyst estimates available to subscribers	$46.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	17.8% EBITDA margin	Analyst estimates available to subscribers	3.8% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$167M	Analyst estimates available to subscribers	$86.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	12.5% EBIT margin	Analyst estimates available to subscribers	7.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$140M	Analyst estimates available to subscribers	$14.0M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	10.5% net profit margin	Analyst estimates available to subscribers	1.2% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	n/a	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Penumbra

This financial data table provides comprehensive performance metrics for Penumbra, a company based in United States of America. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Penumbra generated $1.3B in revenue over the last twelve months.
The company achieved $237M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $888M.
Net income over the last twelve months reached $140M.

Fiscal Year Performance

In the most recent fiscal year, Penumbra reported $1.2B in total revenue.
Fiscal year EBITDA was $46.0M.
The company maintained a gross profit margin of 63.2% in the most recent fiscal year.
EBITDA margin for the fiscal year was 3.8%.
Net profit margin reached 1.2% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Penumbra. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Penumbra Stock Performance

Penumbra has current market cap of $10.2B, and EV of $10.0B.

Market Cap Evolution

Penumbra Stock Data

As of October 13, 2025, Penumbra's stock price is $260.

See Penumbra trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$10.0B	$10.2B	XXX	XXX	XXX	XXX	$3.42

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Penumbra Valuation Multiples

Penumbra's trades at 8.3x EV/Revenue multiple, and 216.5x EV/EBITDA.

See valuation multiples for Penumbra and 15K+ public comps

Penumbra Financial Valuation Multiples

As of October 13, 2025, Penumbra has market cap of $10.2B and EV of $10.0B.

Equity research analysts estimate Penumbra's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Penumbra has a P/E ratio of 72.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$10.2B	XXX	$10.2B	XXX	XXX	XXX
EV (current)	$10.0B	XXX	$10.0B	XXX	XXX	XXX
EV/Revenue	7.5x	XXX	8.3x	XXX	XXX	XXX
EV/EBITDA	41.9x	XXX	216.5x	XXX	XXX	XXX
EV/EBIT	59.8x	XXX	115.5x	XXX	XXX	XXX
EV/Gross Profit	11.2x	XXX	n/a	XXX	XXX	XXX
P/E	72.8x	XXX	725.0x	XXX	XXX	XXX
EV/FCF	50.7x	XXX	67.6x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Penumbra Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Penumbra Margins & Growth Rates

Penumbra's last 12 month revenue growth is 14%

Penumbra's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.1M for the same period.

Penumbra's rule of 40 is 25% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Penumbra's rule of X is 53% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Penumbra and other 15K+ public comps

Penumbra Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	14%	XXX	14%	XXX	XXX	XXX
EBITDA Margin	18%	XXX	4%	XXX	XXX	XXX
EBITDA Growth	24%	XXX	54%	XXX	XXX	XXX
Rule of 40	25%	XXX	18%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	53%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	$0.3M	XXX	XXX	XXX
Opex per Employee	XXX	XXX	$0.1M	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	8%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	56%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial